Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins (Q28344657)
scientific article
Language:
(P31) (Q13442814)
(P304) 10173-8
(P407) (Q1860)
(P433) 18
(P478) 97
(P577) Tuesday, August 29, 2000
(P921) (Q29496)
(Q612108)
(Q29417)
(P1433) (Q1146531)
(P1476) "Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins" (language: en)
(P2093) E M Rego
L Z He
R P Warrell
Z G Wang
P P Pandolfi
(P2860) (Q28343393)
(Q28375997)
(Q28143297)
(Q28370994)
(Q24324026)
(Q28266768)
(Q28263534)
(Q27853402)
(Q28115868)
(Q29616211)
(Q36774571)
(Q33739259)
(Q33178068)
(Q40971408)
(Q33177365)
(Q40986173)
(Q34478428)
(Q41002148)
(Q41007348)
(Q41012996)
(Q41039098)
(Q36771988)
(Q34739789)
(Q34739775)
(Q34735694)
(Q34733855)
(Q34057370)
(Q38298801)
(Q42537956)
(Q42545311)
(Q41640518)
(Q41617101)
(Q41692539)
(Q54147247)
(Q56418625)
(Q72550997)
(Q77920688)
(Q70772271)